ClinicalTrialsFinder

Follicular Lymphoma Grade 3A Clinical Trials in Kaohsiung City

1 recruitingKaohsiung City, Taiwan

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma

Diffuse Large B Cell LymphomaLarge B-cell LymphomaPrimary Mediastinal Large B Cell Lymphoma+2 more
Pell Bio-Med Technology Co., Ltd.49 enrolled5 locationsNCT05326243